SEC Form 4 · accession 0000899243-19-005260
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin D. Gover
Officer — Chief Executive Officer · Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Feb 26, 2019 | M | 22,440 | $0.0013 | A | 392,885 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 11,016 | $12.45 | D | 381,869 | D | |
| Ordinary SharesF3,F4 | Feb 26, 2019 | S | 96 | $12.28 | D | 381,773 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $0.0013 | Feb 26, 2019 | M | 22,440 | D | Feb 26, 2019 | Mar 15, 2020 | Ordinary Shares | 22,440 | 0 | D |
Explanation of responses
- F1Exercise of stock options. Following the exercise, these shares were converted into 1,870 American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.29 U.S. Dollars as of February 26, 2019.
- F3These ordinary shares are represented by ADSs.
- F4The price reported is price per ordinary share converted from price per ADS.